By InvitationNot Applicable

Rare and Undiagnosed Disease Research Biorepository

United States5,000 participantsStarted 2020-11-20

Plain-language summary

This research study is being done to find markers and identify causes of rare and undiagnosed diseases by analyzing patient's DNA (i.e., genetic material), RNA, plasma, urine, tissues, or other samples that could be informative of symptoms. Researchers are creating a biobank (library) of samples and information to learn more about treating rare and undiagnosed diseases.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Has Mayo Clinic or other medical health system ID, or another unique identifier * Able to provide informed consent Must meet one of the following: * Individual must have evidence of a rare disease or a suspected genetic disorder as determined by a provider or genetic counselor * Biological family member of an enrolled individual Exclusion Criteria: * Individuals who have situations that would limit compliance with the study requirements * Institutionalized (i.e. Federal Medical Prison)

What they're measuring

Enrollment of Study Participants

Timeframe: 5 years

Trial details

NCT IDNCT04703179

SponsorMayo Clinic

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-11

View on ClinicalTrials.gov More Undiagnosed Disease trials